Sept. 30, 2025 — A new study from the Harvey L. Neiman Health Policy Institute found that attrition (i.e., exit) from the radiology workforce differed by radiologist and practice characteristics. Significantly higher attrition was observed for female versus male radiologists, subspecialists versus generalists, nonacademic versus academic radiologists, and radiologists in practices with at least one rural site versuss no rural sites.

Sept. 30, 2025 — Sona, the first free, HIPAA-compliant platform that securely delivers ultrasound images directly to patients’ phones, has launched its Exclusive Brand Partnership Program. Sona’s easy to install, free technology, allows OB/GYN practices to offer expecting parents a modern, tech-forward experience while improving patient satisfaction and setting themselves apart from competitors.

Sept. 29, 2025 — Many studies have shown the inverse relationship between bone mineral density (BMD) — the gold standard measure for osteopenia/osteoporosis and coronary calcium (CAC) — a biomarker of heart attack and stroke risk. For example, mild (osteopenia) or more severe (osteoporosis) low BMD is associated with elevated CAC/cardiovascular disease (CVD) risk. A new NIH-funded long term longitudinal study stratifies this association — showing different levels of low BMD corresponding to different levels of elevated CAC.

Sept. 26, 2025 – Accuray Inc. has introduced the Accuray Stellar* solution. Initially for the U.S. market, the new Accuray technology is comprised of a comprehensive tool set designed to empower clinical teams to address the evolving treatment needs of patients undergoing radiotherapy.

The Accuray Stellar solution, a configuration of the Radixact Treatment Delivery System, will be featured at the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting in San Francisco, Calif.

Sept. 26, 2025 ― Researchers from the University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body radiation therapy (SBRT) and surgery achieved similar survival outcomes at 10-year follow-up for patients with early-stage non-small cell lung cancer, with radiation offering quality-of-life benefits. These findings will be presented Sept. 29 by Joe Chang, M.D., Ph.D., professor of Radiation Oncology, and Troy Kleber, M.D., resident.